Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-1-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-1-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors

Published:2018-06 Issue: Volume:154 Page:9-28
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wei Manman,Peng Xia,Xing Li,Dai Yang,Huang Ruimin,Geng Meiyu,Zhang Ao,Ai Jing,Song Zilan^ORCID

Funder

National Natural Science Foundation of China

International Cooperative Program

Chinese Academy of Sciences

Shanghai Commission of Science and Technology

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference44 articles.

1. Targeting FGFR signaling in cancer;Touat;Clin. Canc. Res.,2015

2. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction;Carter;Trends Cell Biol.,2015

3. Fibroblast growth factor signalling: from development to cancer;Turner;Nat. Rev. Canc.,2010

4. Fibroblast growth factor receptors, developmental corruption and malignant disease;Kelleher;Carcinogenesis,2013

5. Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology;Belov;Cold Spring Harbor Perspect. Biol.,2013

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The crystal structure of (3-chlorothiophene-2-carboxylato-κ ² O, O′)-(2,2′-dipyridyl-κ ² N,N′)lead(II), C₂₀H₁₂Cl₂N₂O₄S₂Pb;Zeitschrift für Kristallographie - New Crystal Structures;2024-08-01

2. Discovery of N-(4-((6-(3,5- Dimethoxyphenyl)-9H-purine derivatives as irreversible covalent FGFR inhibitors;European Journal of Medicinal Chemistry;2024-05

3. The crystal structure of hexakis(3-thiophenecarboxylato-κ ² O,O″)-bis(1,10-phenanthroline-κ ² N,N′) trimanganese(II), C₅₄H₃₄N₄O₁₂S₆Mn₃;Zeitschrift für Kristallographie - New Crystal Structures;2023-11-01

4. Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship;Bioorganic Chemistry;2023-09

5. Angiogenic signaling pathways and anti-angiogenic therapy for cancer;Signal Transduction and Targeted Therapy;2023-05-11